# A Marine-Derived Steroid from Rhodococcus sp., 3,12-Dioxochola-4,6-dien-24-oic Acid, Enhances Skin Re-Epithelialization and Tissue Repair

**Authors:** Mücahit Varlı, Hui Tan, Chaeyoung Lee, Jeongyun Lee, Ji Young Lee, Jeong-Hyeon Kim, Songyi Lee, Hangun Kim, Sang-Jip Nam

PMC · DOI: 10.3390/md23070292 · 2025-07-19

## TL;DR

A new marine-derived steroid compound, DOCDA, was found to speed up wound healing by boosting cell movement and activating regenerative signals in skin cells.

## Contribution

The discovery of DOCDA as a novel marine-derived steroid that promotes wound healing through activation of regenerative signaling and stem-like properties.

## Key findings

- DOCDA promotes wound healing by enhancing HaCaT cell invasion and migration and upregulating growth factors like EGF and VEGF-A.
- DOCDA increases expression of genes related to focal adhesion and cytoskeletal regulation, such as ITGB1, FAK, and RHOA.
- Topical application of DOCDA in mice resulted in over 70% wound closure within 5 days.

## Abstract

The discovery of bioactive natural compounds from microbes holds promise for regenerative medicine. In this study, we identified and characterized a steroid-like compound, 3,12-dioxochola-4,6-dien-24-oic acid (DOCDA), from a crude extract of Rhodococcus sp. DOCDA significantly promoted wound healing by enhancing HaCaT cell invasion and migration. It upregulated key growth factors (EGF, VEGF-A, IGF, TGF-β, and HGF), indicating the activation of regenerative signaling. Additionally, DOCDA increased the expression of genes related to focal adhesion and cytoskeletal regulation (ITGB1, ITGA4, FAK, SRC, RHOA, CDC42, RAC1, and paxillin), supporting enhanced cellular motility and remodeling. Notably, DOCDA promoted stem-like properties in HaCaT cells, as shown by increased spheroid formation and elevated levels of the stemness markers ALDH1 and CD44. Target prediction and molecular docking identified the glucocorticoid receptor (GR) as the primary target of DOCDA, with a docking score of −7.7 kcal/mol. Network and pathway enrichment analysis revealed that GR-linked pathways were significantly associated with wound healing, including steroid hormone signaling, inflammation, immune responses, and cell migration. In vivo, the topical application of DOCDA led to over 70% wound closure in mice by day 5. These findings suggest that DOCDA is a steroid-like compound that accelerates wound healing and may serve as a potential agent in regenerative therapy.

## Linked entities

- **Genes:** EGF (epidermal growth factor) [NCBI Gene 1950], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422], IGF1 (insulin like growth factor 1) [NCBI Gene 3479], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], HGF (hepatocyte growth factor) [NCBI Gene 3082], ITGB1 (integrin subunit beta 1) [NCBI Gene 3688], ITGA4 (integrin subunit alpha 4) [NCBI Gene 3676], PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747], SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714], RHOA (ras homolog family member A) [NCBI Gene 387], CDC42 (cell division cycle 42) [NCBI Gene 998], RAC1 (Rac family small GTPase 1) [NCBI Gene 5879], ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216], CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960]
- **Chemicals:** 3,12-dioxochola-4,6-dien-24-oic acid (PubChem CID 5284140)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, CDC42 (cell division cycle 42) [NCBI Gene 998] {aka CDC42Hs, G25K, TKS}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, ITGA4 (integrin subunit alpha 4) [NCBI Gene 3676] {aka CD49D, IA4}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, PXN (paxillin) [NCBI Gene 5829], SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}
- **Diseases:** inflammation (MESH:D007249)
- **Chemicals:** Steroid (MESH:D013256), 3,12-Dioxochola-4,6-dien-24-oic Acid (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rhodococcus sp. (in: high G+C Gram-positive bacteria) (species) [taxon 1831]
- **Cell lines:** HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12299624/full.md

---
Source: https://tomesphere.com/paper/PMC12299624